bezuclastinib
cogent biosciences
['apex']
cogent biosciences presents preclinical data at aacr annual meeting highlighting precision therapy pipeline and announces initiation of part 2 of the registration-enabling apex trial with bezuclastinib in advanced systemic mastocytosis - data describes ... 
CEO Of Digital Media Online